Related Experiment Video
Updated: Apr 18, 2026

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
Management of cardiogenic shock complicating acute myocardial infarction
Jozef L Van Herck1, Marc J Claeys2, Rudi De Paep2
1Department of Intensive Care Medicine and Cardiology, Antwerp University Hospital, University of Antwerp, Belgium jozef.van.herck@uza.be.
Insights
Cardiogenic shock, a complication of acute myocardial infarction, has a poor prognosis. This review covers management strategies, including early revascularization and mechanical circulatory support, referencing European and German-Austrian guidelines.
Area of Science:
- Cardiology
- Critical Care Medicine
Background:
- Cardiogenic shock complicates 5-10% of acute myocardial infarction cases, associated with high mortality.
- Current treatments like inotropes and vasopressors can worsen myocardial oxygen demand and ischemia.
- Mechanical circulatory support use is rising, but robust trial data is limited.
Purpose of the Study:
- To review current literature on cardiogenic shock management.
- To provide an overview of European and German-Austrian guideline recommendations.
- To highlight the role of early revascularization and mechanical support.
Main Methods:
- Literature review of cardiogenic shock management.
- Analysis of European and German-Austrian clinical guidelines.
- Summary of data on percutaneous mechanical circulatory support systems.
Main Results:
- Early revascularization is crucial for myocardial infarction-related cardiogenic shock.
- Hemodynamic stabilization may involve inotropes/vasopressors, but with risks.
- Limited randomized trial data exists for various percutaneous support systems.
Conclusions:
- Management of cardiogenic shock requires a multifaceted approach.
- Guidelines emphasize early revascularization and judicious use of support therapies.
- Further research is needed on mechanical circulatory support efficacy.
Abstract:
Cardiogenic shock complicates approximately 5-10% of cases with acute myocardial infarction and carries a poor prognosis. Early revascularization remains the cornerstone treatment of cardiogenic shock complicating myocardial infarction. Inotropic and/or vasopressor agents can be used for haemodynamic stabilization, although this comes at the expense of increased myocardial oxygen consumption and extended myocardial ischaemia. In recent years, the use of mechanical circulatory support has significantly increased. However, there is only limited data available from randomized trials evaluating the different percutaneous support systems. This review summarizes the available literature concerning the management of cardiogenic shock and gives an overview of the recommendations of the European and German-Austrian guidelines on cardiogenic shock.
Related Concept Videos
Acute Coronary Syndrome IV: Interprofessional Care
Myocarditis III: Medical Management
Cardiopulmonary Resuscitation IV: Pharmacological Management
Heart Failure V: Medical Management
Cardiomyopathy V: Interprofessional Care
Acute Coronary Syndrome V: Nursing Management

